Educational resources

Guidelines in Practice has developed a range of educational resources—including animations, formulary decision guides, implementation checklists, supplements, and webinars—to support you with your learning and implementation of best practice. Items may contain pharmaceutical promotional information.

Guidelines in Practice webinars provide a 1-hour update from expert speakers on the latest evidence and guidance. Available live and on-demand

Screen Shot 2019-10-22 at 11.25.04

Real-world evidence in the management of type 2 diabetes: switching from other DPP‑4 inhibitors to alogliptin (Vipidia®)

2019-10-22T10:22:00+01:00Commissioned by Takeda UK Ltd

This promotional educational webinar has been organised and funded by Takeda UK Ltd. See bottom of page for full disclaimer.

Header image 3 2 small

Nailing your onychomycosis management

2019-05-16T06:45:00+01:00Commissioned by Bayer Plc

Contains promotional content

Guidelines in Practice snapshot animations provide a quick overview of best-practice topics related to clinical guidance and medicines—update your knowledge in 10 minutes

Index picture

Respimat® Soft Mist™ reusable inhaler: patient benefits and environmental impact

2020-03-09T09:22:00+00:00Commissioned by Boehringer Ingelheim Limited

This animation has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines in Practice. Boehringer Ingelheim Ltd suggested the topic and the presenter, and carried out full medical approval on all materials to ensure compliance with regulations. The sponsorship fee included an honorarium for the ...

Guidelines in Practice implementation checklists collate the key recommendations from clinical guidance to help you easily apply them to your practice

If you want to update your knowledge on specific drugs, or need to collate information to support your formulary decisions, read our Guidelines in Practice formulary decision guides

Amgevita FDG

Amgevita® ▼ (adalimumab biosimilar)

2020-01-20T08:45:00+00:00Commissioned by Amgen Ltd

This formulary discussion guide was developed from content provided by Amgen Ltd in a format developed by Guidelines in Practice.

Trajenta formulary decision guide

Trajenta® (linagliptin) 5 mg film-coated tablets

2020-01-02T06:00:00+00:00Promotional material from Boehringer Ingelheim Limited and Lilly Diabetes Alliance

Information intended for healthcare professionals only.

Latest supplements

Guidelines in Practice supplements provide expert opinion articles on a range of clinical and commissioning areas. Our supplement range includes the following types: Product Review; Guidance Update; Local Implementation.

ICS consensus

How should inhaled steroids be used in the management of asthma in adults within a primary care setting?

2020-03-27T11:36:00+00:00Supported by an educational grant from CIPLA EU Ltd

Alan Begg PAD video

Secondary event prevention and risk stratification in patients with symptomatic peripheral arterial disease (PAD)

2019-10-11T13:33:00+01:00Commissioned by Bayer Plc

Information intended for healthcare professionals only. The development of this Guidelines in Practice video has been commissioned by Bayer plc. Please see the bottom of the page for full disclaimer.